Lobbying

Coherus Biosciences's latest lobbying report covers Q2 2026, at $205K. The four quarters Q4 2025–Q3 2026 total $585K. Its first report covers Q4 2022; the issues it reports most are Health Issues and Medicare/Medicaid.

Coherus Biosciences

Latest quarter
No record
Q3 2026 · 0 reports
Last 12 months
$585K
Last 4 quarters
vs last quarter
−100.0%
Q3 2026 against the quarter before
First report
Q4 2022
The first quarter a report named it

Lobbying by quarter

Coherus Biosciences lobbying by quarter
Coherus Biosciences lobbying by quarter
QuarterAmountReports
Q4 2022$465K6
Q1 2023$465K6
Q2 2023$475K7
Q3 2023$475K7
Q4 2023$365K7
Q1 2024$177.5K5
Q2 2024$162.5K5
Q3 2024$105K3
Q4 2024$110K2
Q1 2025$110K2
Q2 2025$220K3
Q3 2025$225K3
Q4 2025$190K3
Q1 2026$190K3
Q2 2026$205K3
Q3 2026$00

By issue

  • Health issues$1.5M · 47 reports
  • Government issues$1.3M · 20 reports
  • Medicare and Medicaid$449.2K · 27 reports
  • Pharmacy$316.7K · 10 reports
  • Defense$135K · 7 reports
  • Intelligence and surveillance$135K · 7 reports
  • Medical research and clinical labs$15K · 5 reports

An issue's amount splits each report's amount equally over the issues the report lists.

Who was lobbied

  • SENATE64 reports
  • HOUSE OF REPRESENTATIVES62 reports
  • Health & Human Services, Dept of (HHS)36 reports
  • White House Office34 reports
  • Defense, Dept of (DOD)22 reports
  • Natl Security Council (NSC)20 reports
  • Executive Office of the President (EOP)16 reports
  • Centers For Medicare and Medicaid Services (CMS)15 reports
  • Food & Drug Administration (FDA)15 reports
  • Office of Management & Budget (OMB)15 reports
  • Office of Science & Technology Policy (OSTP)15 reports
  • Commerce, Dept of (DOC)10 reports
  • Energy, Dept of9 reports
  • Defense Advanced Research Projects Agency (DARPA)6 reports
  • Defense Nuclear Facilities Safety Board6 reports
  • Federal Emergency Management Agency (FEMA)6 reports
  • President of the U.S.6 reports
  • Vice President of the U.S.6 reports
  • Homeland Security, Dept of (DHS)5 reports
  • Export-Import Bank of the United States (EXIM Bank)2 reports

Firms it paid

Firm
In-houseCoherus Biosciences$2.1M15 quarters
Inlet Strategies$725K15 quarters
The McKeon Group$315K8 quarters
Foley & Lardner$250K5 quarters
Red+blue Strategies$250K5 quarters
Capitol Hill Consulting Group$200K5 quarters
Alston & Bird$40K7 quarters
The Conafay Group$30K5 quarters

Former officials lobbying for it

Former position
DAVID SANDERSLegislative Affairs, Dept of Commerce, US Patent and Trademark Office (2005-2007) Legislative Assistant, Representative Marsha Blackburn (2002-2004) Legislative and Press Intern, Senator Fred Thompson (2000)Q2 2026
JOHN STROMSenior Counsel - U.S. House Cmte on Energy & Commerce; Counsel - U.S. Senate Cmte on Health, Education, Labor, and Pensions; Associate General Counsel - U.S. Dept of Health and Human Services; Senior Counsel - U.S. House Cmte on Natural ResourcesQ2 2026
KENDRA WHARTONAssociate Deputy Attorney General, United States Department of Justice. January 2025 - July 2005: Legislative Aide, Senator Mitch McConnell. May 2008 - November 2012Q2 2026
THOMAS WHARTONLegislative Assistant. Senator Lieberman May 2011-June 2012 Senior Legislative Assistant. Representative Dan Boren. July 2008-June 2011Q2 2026
BEN KENNEYCMS, HHSQ2 2024
BRYAN SHUYChief of Staff Rep. Harris; Asst. to Rep. Harris, House Cmte on Approps; Dep. Asst. Sec and Chief of Staff HHS/Asst. Secretary for Preparedness and Response (ASPR)Q2 2024
DARIN L GARDNERLegislative Correspondent Senator Tim Hutchinson; Research Associate Senate HELP Committee; Chief of Staff Congresswoman Kay GrangerQ2 2024
JOSH NARROWIntern for Senator CaseyQ2 2024
BRIAN SUTTERStaff Dir. W&M Health subcommittee, Chairman Dave Camp April'13-Dec'14. Professional Staff, W&M Health subcommittee, Chairman Dave Camp, Jan'11-April'13. Leg Dir. Rep Dave Camp, May'08-Jan'11. Leg Asst Rep Dave Camp, Feb'03-May'08. Staff Ast July'02Q4 2023
CHRISTOPHER DAVISStaff Assistant, Legislative Assistant, Senior Legislative Assistant, and Legislative Director - Rep. Rick Boucher (2006-2011).Q4 2023
EMILY ELIZABETH WILKINSON-HOLLANDStaff -Rep. Price (2010-11), LA: Rep. Grimm (2011-12), Rep. Black (2012-13), Sen.Vitter (2013-2015), Sen. Heller (2015-17), Policy Adv. to the Sec.- Dept of HHS (3/2017-8/2017), Sr Advisor to Administrator - Ctrs for Medicare & Medicaid (8/17- 5/19)Q4 2023
MARK RAYDERLA, Rep. Tom Latham; LA, Rep. Rodney Frelinghuysen; District Rep., Rep. Dean Gallo.Q2 2023
EARL POMEROYCongressman, U.S. House of RepresentativesQ4 2022

Lobbying reports

Filed by
07/28for Q2In-house$95K
07/20for Q2Inlet Strategies$60K
07/19for Q2Foley & Lardner$50K
05/18for Q1In-house$80K
04/20for Q1Foley & Lardner$50K
04/19for Q1Inlet Strategies$60K
03/09for Q4 2025In-house$80K
01/19for Q4 2025Foley & Lardner$50K
01/18for Q4 2025Inlet Strategies$60K
25/10/22for Q4 2025In-house$80K
25/10/18for Q3 2025Foley & Lardner$50K
25/10/15for Q3 2025Inlet Strategies$50K
25/08/18for Q3 2025In-house$125K
25/08/18for Q2 2025In-house$125K
25/07/21for Q2 2025Foley & Lardner$50K
25/07/18for Q2 2025Foley & LardnerUnder $5,000
25/07/14for Q2 2025Inlet Strategies$45K
25/04/14for Q1 2025Inlet Strategies$45K
25/03/24for Q1 2025In-house$65K
25/03/24for Q4 2024In-house$65K